LASER VERSUS CRYSTALLIZED PHENOL IN PILONIDAL SINUS DISEASE
Sponsor: Sanliurfa Education and Research Hospital • ClinicalTrials.gov ID: NCT07701772
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This single-center prospective randomized parallel-group trial compares laser ablation and crystallized phenol application in adults with primary uncomplicated sacrococcygeal pilonidal sinus disease. The primary objective is to compare postoperative day 1 pain intensity between the two treatment methods. Secondary objectives include complete epithelialization by day 30, time to complete epithelialization, postoperative day 7 pain, duration of analgesic use, time to return to daily activities and work, early local complications, and 6-month recurrence.
Interventions
-
Laser Ablation
(Procedure)
After a small incision, hair and debris removal, and curettage, laser ablation is performed using a Leonardo Mini 1470 nm diode laser.
-
Crystallized phenol application
(Procedure)
After a small incision, hair and debris removal, and curettage, crystallized phenol is applied to the sinus cavity.
Eligibility criteria
Conditions
Locations
- Sanliurfa Education and Research Hospital — Sanliurfa, Şanlıurfa, Turkey (Türkiye)
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record